RespireRx Pharmaceuticals Inc. — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2022)

-$2.1M

Total Assets (FY2022)

$22.8K

Total Equity (FY2022)

-$11.9M

Cash Flows from Operating Activities (FY2022)

-$143.9K

Source: RespireRx Pharmaceuticals Inc. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.